Flow Control Devices for Optimizing Fluid Dynamics in Diverse Industries
Legal Citation
Summary of the Inventive Concept
The inventive concept applies the core technology of high resistance implanted bronchial isolation devices to novel applications in hydraulic fracturing, agricultural irrigation, flood damage mitigation, and stormwater runoff management, enabling optimized fluid flow dynamics and improved outcomes in these industries.
Background and Problem Solved
The original patent addressed the need for improved lung disease treatment through implanted bronchial isolation devices. However, the underlying technology has broader applicability to other fields where fluid flow control is critical. The inventive concept solves the problem of inefficient fluid flow dynamics in various industries, leading to reduced productivity, wasted resources, and environmental concerns.
Detailed Description of the Inventive Concept
The flow control devices in the new claims are adapted to regulate fluid flow in different industries, transitioning between closed and open configurations to achieve desired fluid flow dynamics. In hydraulic fracturing, the device optimizes fluid injection and extraction. In agricultural irrigation, it controls water supply and drainage. In flood damage mitigation, it regulates water flow to prevent flooding. In stormwater runoff management, it manages stormwater inflow and outflow. The devices' design and operation are tailored to each industry's specific requirements, leveraging the original patent's valve technology.
Novelty and Inventive Step
The new claims introduce novel applications of the flow control device technology, moving beyond the original patent's focus on lung disease treatment. The inventive step lies in recognizing the potential for this technology to be adapted and optimized for diverse industries, addressing specific fluid flow challenges and opportunities.
Alternative Embodiments and Variations
Alternative embodiments could include variations in device design, materials, and operation to suit different industries' needs. For example, the device could be integrated with sensors and automation systems to optimize fluid flow in real-time. Other variations might involve modifying the valve configuration, incorporating additional features, or using different materials to enhance durability and performance.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the industries mentioned, with potential applications in oil and gas production, agricultural productivity, flood damage mitigation, and urban stormwater management. The market for these applications is substantial, with opportunities for licensing, partnerships, and product development.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61F2/04 |
| A | A61 | A61M16/209 |
| A | A61 | A61F2002/043 |
| A | A61 | A61M2205/04 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device engineering and fluid control systems, with expertise in valve mechanisms, biomedical implants, and fluid dynamic regulation across medical and industrial applications
Person of Ordinary Skill (PHOSITA) Profile
A skilled engineer with advanced degrees in biomedical engineering or mechanical engineering, capable of understanding complex valve mechanisms, fluid flow dynamics, and cross-industry technology adaptation
Obviousness Rationale
A PHOSITA would recognize that the core valve mechanism from the bronchial isolation device represents a generalizable fluid control technology with broad applicability beyond medical contexts. The fundamental principles of directional flow control, transitional valve configurations, and selective fluid passage are technically transferable across different industrial domains. The PTD demonstrates predictable engineering extension by applying the source patent's core mechanical principles to alternative fluid management scenarios.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,406 |
|---|---|
| Title | High resistance implanted bronchial isolation devices and methods |
| Assignee(s) | Pulmonx Corporation |